Almirall to acquire products from Allergan's US medical dermatology portfolio; finalizes deal for up to $650mm
Almirall SA agreed to acquire a portfolio of four products and one late-phase compound from Allergan PLC's US medical dermatology unit, a part of the Irish company's US specialized therapeutics business segment.
- Topical Delivery
- Drug Delivery
- Marketing (Licensing)
- Product Purchase
Please contact Sales at: (212) 520-2765 or email [email protected]
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.